gms | German Medical Science

66. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Friendship Meeting mit der Italienischen Gesellschaft für Neurochirurgie (SINch)

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

7. - 10. Juni 2015, Karlsruhe

Innovative and atypical approaches of peripheral nerve field stimulation (PNFS) for chronic neuropathic pain syndromes: A series of 3 cases

Meeting Abstract

Suche in Medline nach

  • Katharina Graf - Klinik für Neurochirurgie, Justus- Liebig Universität Gießen, Gießen
  • Frank Schwarm - Klinik für Neurochirurgie, Justus- Liebig Universität Gießen, Gießen
  • Eberhard Uhl - Klinik für Neurochirurgie, Justus- Liebig Universität Gießen, Gießen
  • Malgorzata Kolodziej - Klinik für Neurochirurgie, Justus- Liebig Universität Gießen, Gießen

Deutsche Gesellschaft für Neurochirurgie. 66. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC). Karlsruhe, 07.-10.06.2015. Düsseldorf: German Medical Science GMS Publishing House; 2015. DocP 095

doi: 10.3205/15dgnc493, urn:nbn:de:0183-15dgnc4935

Veröffentlicht: 2. Juni 2015

© 2015 Graf et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.


Gliederung

Text

Objective: Peripheral nerve field stimulation (PNFS) is a well-known modality in the treatment of chronic low back pain. Chronic pain is a relatively common result of severe skin damage from burns and in Lyme disease. Depending on the cause and degree of injury, most people can recover without serious health consequences. In case of chronic neuropathic pain syndromes, pain management options for these patients have been mostly limited to pharmaceutical treatments.

Method: Two female patients with a chronic neuropathic pain syndrome after a history of Borreliosis (Lyme disease) and one male patient with chronic neuropathic pain on the right collar following a skin-damage from a burn failed to respond to medication and physical therapy in a multimodal therapy concept. The patients were treated by peripheral nerve field stimulation. Afterwards the neurostimulator was implanted after significant pain relief with a minimum of 70%. The Visual analog scale (VAS) assessed pain before and after the implantation as well as 3 and 6 months postoperatively.

Results: Significant pain relief was achieved in all three patients. In the male patient the 10 point mean VAS score was reduced from 8 to 3. The two female patients had a VAS score reduction from 9 to 2 and 6 to 2, respectively. An improvement of the quality of life and the daily activity level were further achieved and accompanied by a sustained reduction in demand for analgesics. All patients showed a good compliance in handling the neurostimulator.

Conclusions: Peripheral nerve field stimulation is an effective and safe alternative option to relieve chronic pain originating from atypical neuropathic pain syndromes if conservative treatment modalities fail. The preoperative selection plays a crucial role for good results.